Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PhaseBio Pharmaceuticals Inc | SVP and General Counsel | Common Stock | 8.46K | May 20, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PHASQ | PhaseBio Pharmaceuticals Inc | May 20, 2022 | 1 | $3.29K | 4 | May 24, 2022 | SVP and General Counsel |
PHASQ | PhaseBio Pharmaceuticals Inc | Feb 24, 2022 | 2 | $0 | 4 | Feb 28, 2022 | VP, Head of Legal |
PHASQ | PhaseBio Pharmaceuticals Inc | Nov 19, 2021 | 1 | $3.11K | 4 | Nov 23, 2021 | VP, Head of Legal |
PHASQ | PhaseBio Pharmaceuticals Inc | May 20, 2021 | 1 | $3.05K | 4 | May 24, 2021 | VP, Head of Legal |